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Abstract
Background
Despite being the most widely distributed mosquito-borne viral infection, estimates of den-
gue transmission intensity and associated burden remain ambiguous. With advances in the
development of novel control measures, obtaining robust estimates of average dengue
transmission intensity is key for assessing the burden of disease and the likely impact of
interventions.
Methodology/Principle Findings
We estimated the force of infection (λ) and corresponding basic reproduction numbers (R0)
by fitting catalytic models to age-stratified incidence data identified from the literature. We
compared estimates derived from incidence and seroprevalence data and assessed the
level of under-reporting of dengue disease. In addition, we estimated the relative contribu-
tion of primary to quaternary infections to the observed burden of dengue disease inci-
dence. The majority of R0 estimates ranged from one to five and the force of infection
estimates from incidence data were consistent with those previously estimated from sero-
prevalence data. The baseline reporting rate (or the probability of detecting a secondary
infection) was generally low (<25%) and varied within and between countries.
Conclusions/Significance
As expected, estimates varied widely across and within countries, highlighting the spatio-
temporally heterogeneous nature of dengue transmission. Although seroprevalence data
provide the maximum information, the incidence models presented in this paper provide a
method for estimating dengue transmission intensity from age-stratified incidence data,
which will be an important consideration in areas where seroprevalence data are not
available.
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Author Summary
With 40% of the world’s population at risk of infection, dengue imposes a significant pub-
lic health burden. Yet estimates of baseline transmission intensity are still sparse, making
it difficult to implement efficient control programs. The authors used incidence data,
which are abundant compared to seroprevalence data, to estimate dengue transmission
intensity in 13 countries. Estimates derived from incidence data were comparable to those
from seroprevalence data, an important conclusion for areas where seroprevalence data
are not available. Additionally, the estimated baseline reporting rates and the contribution
of primary to tertiary/quaternary infections to observed disease in each country will help
to highlight potential weaknesses in the country or region’s surveillance system.
Introduction
Dengue is the most widely distributed mosquito-borne viral infection, but assessment of its
geographic variation in transmission remains challenging. Analysis based on mapping the
probability of occurrence of dengue estimated that dengue causes 390 million annual infections
worldwide [1]. However, these estimates relied on assuming a direct linear correlation between
the probability of occurrence and incidence, rather than estimating transmission intensity as
quantified by the force of infection or reproduction number. Here we develop methods to esti-
mate transmission intensity from routine, age-stratified surveillance data on suspected dengue
case incidence.
All four serotypes of dengue virus (DENV-1, 2, 3, and 4) can cause dengue fever with the
risk of severe dengue increasing with subsequent heterologous infections. Once infected, indi-
viduals develop long-lived protective homotypic immunity and short-lived heterotypic immu-
nity [2,3]. Once antibody levels wane below the threshold required to provide protection,
antibody-dependent enhancement (ADE) becomes a risk, leading to secondary heterologous
infection having an increased risk of causing clinically apparent disease [4,5]. Hence, while the
majority of primary dengue infections are asymptomatic [6,7], secondary heterologous infec-
tion has been identified as a major risk factor for symptomatic and severe dengue [8–10].
Therefore the majority of cases seen in hospitals [11] or reported via surveillance systems [12]
tend to be secondary infections [7].
In previous work, we estimated dengue transmission intensity from age-stratified seropreva-
lence data but highlighted the relative paucity of seroprevalence data compared with routine
surveillance data on the incidence of suspected dengue [13]. This reflects dengue fever, dengue
haemorrhagic fever (DHF), and dengue shock syndrome (DSS) being notifiable diseases in
most countries [14–18]. Indeed, in many countries, incidence reports are the only type of data
available. However the clinical diagnostic criteria vary and different countries have their own
reporting standards [19]. The World Health Organisation (WHO) collates surveillance data
from dengue affected countries via its DengueNet system, but the data are not always updated
regularly and there can be inconsistencies with other sources (e.g. WHO regional offices or
countries) of national and subnational data [19].
The lack of systematic data on dengue incidence, the lack of standardised reporting proce-
dures or diagnostic criteria, and the lack of integration between private and public sectors
makes accurate estimation of the true dengue burden difficult [20]. Previous studies have
attempted to estimate the burden of dengue and associated economic costs in South East Asia
and South America by calculating expansion factors from systematic literature reviews, collation
of existing data, and population-based cohorts [20–24]. However, the lack of standardisation
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also affects the validity of expansion factors (calculated by dividing the cumulative incidence of
dengue cohort studies by that from passive data at national and local levels) as estimates of
underreporting. Due to the wide spectrum of clinical manifestations and the lack of routine lab-
oratory testing, dengue is globally underreported and analyses of officially reported dengue
numbers need to take this into account [25].
While reported incidence levels cannot be relied upon to directly quantify disease burden,
the age distribution of dengue cases provides more reliable information on dengue transmis-
sion intensity. Here we propose an approach for estimating average transmission intensity—as
quantified by the force of infection (λ) or basic reproduction number (R0)–from age-stratified
incidence data. We compare estimates derived from seroprevalence and incidence data and
assess the level of under-reporting of dengue disease. In addition, we estimate the relative con-
tribution of primary to quaternary infections to the observed burden of dengue disease
incidence.
Methods
Literature search
Web of Knowledge and PubMed were searched for age-stratified incidence data since 1980 as
we were interested in contemporary dengue transmission and wanted to be consistent with our
previous study where we collated age-stratified seroprevalence data [13]. Search terms used
were ‘dengue’ and ‘age’ and (‘incidence’ or ‘cases’ or ‘notifications’ or ‘notified cases’) with
inclusion criteria mapped to subject headings. Additional web-based searches were performed
to augment the primary literature search. Data were extracted from published datasets where
authors reported age-stratified incidence data with corresponding population age-structure
data.
Estimating the force of infection and reporting rates
We considered a population stratified intoM age groups and denote aj and aj+1 the lower and
upper age bounds respectively of age group j (j = 0,. . .,M-1). Our model assumes perfect
homotypic protection following infection with any serotype. Thus, an individual can experi-
ence a maximum of four dengue infections in their life (corresponding to the four dengue sero-
types). Ideally, we would allow forces of infection to vary by serotype (DENV-1 to DENV-4).
However as serotype-specific data were not available, we assumed circulating serotypes were
equally transmissible, i.e. had the same force of infection, λ, which did not vary over time. The
incidence of primary infections (I1) for any one serotype for people in an age group j was calcu-
lated as the integral of the probability of being seronegative to all four strains at age amulti-
plied by four times the constant serotype-specific infection hazard, λ (since primary infection
can occur with any of the four serotypes). Age a spans the range [aj,aj+1], as described by the
bounds of integrations (Eq 1).
I1ðjÞ ¼
Z ajþ1
aj
4lðelaÞ4da
¼
Z ajþ1
aj
4le4lada ¼ ðe4laj  e4lajþ1Þ
ð1Þ
The incidence of secondary, tertiary, and quaternary infections in age group j (I2(j), I3(j),
and I4(j) respectively) are calculated in a similar fashion. If fewer than four serotypes have cir-
culated in an area, then the number of infections an individual can have changes accordingly.
Full details are given in the Supporting Information (S1 Text).
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The average observed annual disease incidence rate per person in age group j is then given
by the weighted sum of the primary to quaternary infection rates (Eq 2):
DðjÞ ¼ r
wðjÞ fI2ðjÞ þ g1ðI1ðjÞ þ g3ðI3ðjÞ þ I4ðjÞÞÞ þ Bg ð2Þ
where w(j) = aj+1 − aj is the width of age group j, ρ is the probability that a secondary infection
results in a detected dengue case (reporting rate), γ1 is the probability that a primary infection
is detected relative to a secondary infection, and γ3 is the probability that a tertiary or quater-
nary infection is detected relative to a primary infection. Here B is a baseline risk of disease
used to represent any non-dengue related illnesses that are misdiagnosed as dengue, and was
only estimated when ﬁtting suspected dengue incidence data where laboratory conﬁrmation
was lacking.
We assumed that secondary infections were more likely to be symptomatic than primary
infections [7,26] and that post-secondary infections were even less likely to be symptomatic
than primary infections, i.e. ρ>γ1>γ3. Single values of γ1 and γ3 were estimated per country.
For datasets that reported DHF only, we assumed that DHF cases only arose from secondary
infections and set γ1 and γ3 to zero [27,28]. Where fewer than four serotypes were in circula-
tion, we adjusted our calculation of the expected incidence accordingly—full details are given
in the S1 Text. Where data on the age distribution of the population was not provided in the
source publications, the population age-structure closest to the survey population was used
(taken from census data or from United Nations estimates) [29]. For the first model variant
examined (model 1), we assumed a single baseline reporting rate (ρ) across all age groups. We
also explored whether baseline reporting rates might differ with age (model 2) by estimating
different reporting rates in children (ρyoung) and adults (ρold), also fitting the age threshold
(athreshold) defining the boundary between these groups (ρyoung) for age a< athreshold, otherwise
ρold).
Where incidence data were available for multiple years, we fitted models 1 and 2 to individ-
ual years (model variants 1A and 2A). We also examined fitting to the cumulative incidence
across the observation period, as this gives a better estimate of the long-term average distribu-
tion of incidence across age groups (models 1B and 2B). When fitting to the cumulative inci-
dence we calculated the expected disease incidence by multiplying the annual expected disease
incidence by the number of years in the study. Overall, for models 1A and 1B, we estimated up
to 5 parameters (λ, ρ, γ1, γ3 and B), while for models 2A and 2B we estimated up 7 parameters
(λ, ρyoung, ρold, athreshold, γ1, γ3 and B). All models were fitted to the data using a Metropolis-
Hastings Markov Chain Monte Carlo (MHMCMC) algorithm using a Dirichlet-multinomial
log-likelihood with uniform priors in version 3.1.0 of the R statistical language [30]. Full details
are given in the S1 Text.
Calculating the basic reproduction number (R0)
We assumed dengue transmission was at endemic equilibrium and that the force of infection
(λ) was constant in time. Since we did not have serotype-specific data, we additionally assumed
that all serotypes in circulation were equally abundant and equally transmissible, i.e. had the
same force of infection and basic reproduction number, and that there were no interactions
between serotypes. We estimated a strain-specific basic reproduction number (R0) from the
single force of infection (λ) estimated under two different assumptions about the number of
infections required to acquire complete immunity. Under assumption one, complete protection
is acquired upon quaternary infection. Under assumption two, complete protection is reached
after secondary infection (or if tertiary and quaternary infections occur, they are not
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infectious). These assumptions match that of our previous work estimating the force of infec-
tion from serological data and allowed us to compare the R0 estimates obtained from both
types of data [13]. Full details are given in the S1 Text.
Comparing force of infection estimates by data type
We used weighted regression to assess how comparable force of infection estimates obtained
from cumulative incidence data were with those derived from seroprevalence data described
previously [13] and from four additional seroprevalence datasets (see Table S1 in S1 Text).
Location- and time-matched incidence and serology data were not available, so we matched
datasets by country, region, and survey year. Since seroprevalence data represent all past infec-
tions, we compared force of infection estimates with those obtained from cumulative incidence
data rather than yearly incidence data where possible (see Table S2 in S1 Text for full details on
pairings). We used the weighted regression method described by Ripley and Thompson [31]
which explicitly accounts for measurement errors in both force of infection estimates from
seroprevalence data (y-axis) and incidence data (x-axis) to estimate the maximum likelihood
estimate (MLE) line. This was implemented using the deming package in R [32]. Full details are
given in the S1 Text.
Results
We identified 23 papers reporting incidence data. Fig 1 describes the search process and
Table 1 summarises the studies identified. Seven papers reported age-stratified incidence data
from multiple years, one paper reported data where the number of serotypes in circulation had
changed over the survey years, six papers reported cumulative age-stratified incidence data,
eight papers reported age-stratified incidence data from a single year, and two papers reported
age-stratified incidence data from multiple countries.
The identified studies provided a total of 34 datasets from 13 countries. The years included
ranged from 1978 to 2011. The dataset reporting incidence data from 1978 was included since
data were presented for the eleven-year time period of 1978–1988 [33]. Of the 23 papers
reporting incidence data, ten reported dengue incidence at the national level and only two stud-
ies reported cases detected via active as well as passive surveillance. Three additional surveys
were obtained from the Ministry of Health in Thailand that reported age-specific incidence
from Bangkok (2000), Ratchaburi (2000), and Rayong (2010) [34].
As expected, force of infection estimates varied widely between countries, with less variation
seen within countries. Fig 2 shows the distribution of the total force of infection (λtotal) grouped
by country (calculated by multiplying the serotype-specific force of infection by the number of
serotypes in circulation). Individual estimates are given in the S1 Text.
Estimates of R0 varied according to the assumptions made regarding host immunity.
Assuming only primary and secondary infections are infectious (assumption two) gave up to
two-fold higher estimates of R0 than when assuming tertiary and quaternary infections are also
infectious (Fig 2). This is consistent with our previous results analysing seroprevalence data
[13]. Some force of infection estimates in Cambodia were very high, perhaps as a result of the
active surveillance undertaken as part of the study by Vong et al. [38] (for all parameter esti-
mates see S1 Text). The baseline reporting rate (ρ), defined as the probability of detecting a sec-
ondary infection, was less than 15% when averaged across all studies (Fig 3). The median
probability of detecting a primary infection relative to that of detecting a secondary infection
(γ1) was less than 25% for the majority of datasets. However, the credible intervals for some γ1
estimates were wide. The data proved uninformative about the contribution of post-secondary
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infections to disease incidence, as our estimates of γ3 (Fig 3) reflected the prior distribution
assumed for that parameter (uniform from 0 to 1).
The baseline reporting rates (ρ) varied substantially by country (Fig 3), likely reflecting dif-
ferences in healthcare seeking behaviour and surveillance. Generally, estimated reporting rates
in the Americas were higher than in South East Asia, with Singapore having the highest rate
within SE Asia. Reporting rates also varied within each country depending on survey year or
survey region, which may reflect differences in local healthcare systems or changes in public
awareness after epidemics.
We used weighted regression to compare the force of infection estimates obtained from age-
stratified seroprevalence data to cumulative incidence data. Estimates obtained from the model
fitted to the cumulative incidence data were largely comparable to force of infection estimates
from seroprevalence data (Fig 4). The majority of the total force of infection (λtotal) estimates
from incidence data (calculated by multiplying the serotype-specific force of infection by the
number of serotypes in circulation) were comparable to those obtained from seroprevalence
data when λtotal was smaller than ~0.1 with greater uncertainty as the force of infection
Fig 1. Flowchart describing the literature search process for age-stratified incidence data.
doi:10.1371/journal.pntd.0004833.g001
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Table 1. Summary of cross-sectional incidence datasets identified and associated demographics.
Country Survey
Year
Region Diagnosis # serotypes
in
circulation
DF/DHF/
DSS
Age range
sampled
Estimated
denominator
population of
study (3sf)^
Population
size of study
region
Urban/
Rural
Ref
Brazil 1995–2001 Pernambuco
State
Lab conﬁrmed 2 All cases 0–80+ 8360000 8.5M Urban/Rural [35]
2002–2006 Pernambuco
State
Lab conﬁrmed 3 All cases 0–80+ 8360000 8.5M Urban/Rural [35]
2000–2009 Vitoria Lab conﬁrmed 3 All cases 0–80+ 292000 0.28M–0.32M Urban/Rural [36]
2001–2006 Amazon Clinical 4 All cases 0–70 3480000 23.6M Rural/Urban [37]
Cambodia 2006–2008 Kampong
Chan Province
Lab
conﬁrmed*
4 All cases 0–20 805000 90000 Urban/Rural [38]
2006–2007 Kampong
Chan
Lab conﬁrmed 4 All cases 0–14 14500 90000 Urban/Rural [39]
China 1978–1988 Guangzhou Clinical 4 All cases 0–71+ 69700000 11.64M Urban [33]
1989–1999 Guangzhou Clinical 4 All cases 0–71+ 69000000 11.64M Urban [33]
2000–2009 Guangzhou Clinical 4 All cases 0–71+ 39500000 11.64M Urban [33]
2005–2011 Guangdong Clinical 4 All cases 0–80+ 88900000 104.3M Urban [14]
Laos 2000–2006 National Clinical/Lab 4 All cases 0–15+ 4980000 5.4M Urban/Rural [40]
2010 Savannakhet
Province
Clinical 4 All cases 0–40+ 4880000 0.83M Urban [41]
2010 National Clinical 4 All cases 0–40+ 6390000 6.5M Urban/Rural [42]
Nicaragua 1999–2001 Leon Lab conﬁrmed 3 All cases 0–55 360000 0.39M Urban [43]
Philippines 1998–2005 National Clinical/Lab 4 All cases 0–15+ 71700000 77.7M Urban/Rural [40]
Puerto
Rico
2006 Patillas Lab conﬁrmed 4 All cases 0–40+ 16700 20200 Urban [44]
2007 National Lab conﬁrmed 4 All cases 0–70+ 3820000 3.8M Urban/Rural [45]
2010 National Lab conﬁrmed 4 All cases 0–70+ 3720000 3.7M Urban/Rural [12]
1994 National Lab conﬁrmed 3 All cases 0–75+ 3530000 3.5M Urban/Rural [46]
1995–1997 National Lab conﬁrmed 3 All cases 0–75+ 3530000 3.5M Urban/Rural [46]
Singapore 1999–2005 National Clinical/Lab 4 All cases 0–15+ 2620000 4M Urban [40]
2005 National Lab conﬁrmed 4 DF/DHF 0–80 3450000 4.3M Urban [47]
2005 National Lab conﬁrmed 4 All cases 0–55+ 4270000 4.3M Urban [48]
2007 National Lab conﬁrmed 4 All cases 1–55+ 4590000 4.6M Urban [48]
Sri Lanka 1997 National Clinical 4 DF/DHF 0–65 17300000 17.3M Urban/Rural [49]
1996–2005 National Clinical 4 All cases 0–15+ 17700000 17.3M Urban/Rural [40]
Taiwan 2003–2009 Kaohsiung
City
Lab conﬁrmed 4 All cases 0–74+ 10600000 1.5M Urban [50]
Thailand 2000–2010 National Clinical 4 All cases 0–65+ 797000 66.4M Urban/Rural [51]
2006–2007 Ratchaburi Lab conﬁrmed 4 All cases 0–14 6380 38208 Urban [39]
2000 Bangkok Lab conﬁrmed 4 DHF 0–65 5050 6355144 Urban [34]
2000 Ratchaburi Lab conﬁrmed 4 DHF 0–65 1370 791217 Urban [34]
2010 Rayong Lab conﬁrmed 4 All cases 0–72 1060 616916 Urban [34]
Vietnam 1998–2009 Hanoi Lab conﬁrmed 4 All cases 0–80 6350000 6.5M Urban [52]
Yemen 2010 Hadramout Lab conﬁrmed 3 All cases 0–55+ 797000 0.7M Urban/Rural [53]
*with active surveillance.
^Calculated from the population size and reported incidence if survey numbers were not given in the source publication.
doi:10.1371/journal.pntd.0004833.t001
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increased. In two of the three locations in Thailand where region and time matching seropreva-
lence and incidence data were available [34], the force of infection estimates obtained from the
models fitted to incidence data and serology data had overlapping 95% credible intervals. In
Ratchaburi the estimate obtained from seroprevalence data was smaller than that from inci-
dence data (Fig 5).
Discussion
From a literature search we selected 23 papers reporting age-stratified case notification data in
13 countries from 1978–2010. For each dataset we estimated dengue transmission intensity as
quantified by the force of infection (λ) and the basic reproduction number (R0). Where possible
we fitted to the cumulative incidence data as fitting to yearly incidence data gave less stable
Fig 2. Total force of infection and corresponding R0 estimates from themodel fitted to the incidence data grouped by
country. Each dot represents the posterior median estimate and the error bars show the 95%CrI for each dataset. The
box represents the country-specific central estimate calculated by taking the mean values of the MCMC output for each country (the
line and limits of the box represents the posterior median and the 95% CrI respectively). R0 assumption one: complete protection
acquired upon quaternary infection, assumption two: complete protection reached after secondary infection.
doi:10.1371/journal.pntd.0004833.g002
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estimates (model fits to yearly incidence data are given in the S1 Text) The total force of infec-
tion (λtotal) estimated from cumulative incidence data were then compared with previous λ
estimates from seroprevalence data.
The incidence model presented in this paper provides a method for estimating dengue
transmission intensity in areas where seroprevalence data are not available. Force of infection
estimates and corresponding basic reproduction numbers varied widely across and within
countries as expected, highlighting the heterogeneous nature of dengue transmission spatially
and temporally. The majority of our R0 estimates ranged from 1 to 5, similar to our estimates
obtained from seroprevalence data [13]. Similarly to our serology-based estimates, force of
infection estimates were generally higher in South East Asia than for Latin America. Since we
had no serotype-specific notification data, we assumed that all serotypes were equally
Fig 3. Summary of estimated reporting rates showing the baseline reporting rate or probability of detecting a secondary
infection (ρ), the probability of detecting a primary infection (γ1) relative to a secondary infection, and the probability of
detecting a tertiary/quaternary infection (γ3) relative to a primary infection. Each point represents the posterior median
estimate and the error bars show the 95% CrI for each dataset. The box represents the country-specific central estimate calculated
by taking the mean values of the MCMC output for each country (the line and limits of the box represents the posterior median and
the 95% CrI respectively). A single overall value of γ1 and γ3 were estimated per country.
doi:10.1371/journal.pntd.0004833.g003
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transmissible and equally abundant. If serotype-specific notification data were available, sero-
type-specific forces of infection could be estimated. Although we assumed that dengue trans-
mission intensity does not vary with age, is constant in time and equal for all serotypes in
circulation, previous studies have shown that transmissibility can differ substantially not only
between serotypes [13,54] but also seasonally, yearly [54], and spatially [55]. However, given
the available data it was not possible to estimate serotype-specific or time-varying forces of
infection. Multiple cross-sectional surveys or cohort studies are required to estimate how forces
of infection have changed by age over time, and serotype-specific data are needed to resolve dif-
ferences between serotypes.
Due to the lack of incidence and serology data collected in the same year and region, we
matched cumulative incidence and serology datasets according to the year or region (see S1
Text). While overall estimates from incidence data were comparable with those derived from
seroprevalence data, it would nonetheless be beneficial to validate this model with more inci-
dence and serology datasets collected simultaneously in the same geographical location.
Generally, estimated reporting rates (ρ) in the Americas were higher than those in South
East Asia with Singapore having the highest rate within South East Asia, consistent with their
well-established dengue surveillance program [56]. Reporting rate estimates also varied within
Fig 4. Comparison of weighted deming regression of force of infection estimates by country from cumulative incidence
data and seroprevalence data. Each point is weighted depending on the error in both serology and incidence estimates,
represented by the size of circles (larger circles indicating greater weight, i.e. smaller error).
doi:10.1371/journal.pntd.0004833.g004
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each country depending on survey year or survey region reflecting variation in healthcare and
surveillance systems [19]. Reporting rates are also likely to change in response to recent or cur-
rent epidemics which affect public awareness of dengue and thus healthcare seeking behaviour
[57]. Additionally, in an epidemic year clinicians may preferentially diagnose a febrile illness as
dengue without laboratory testing [58]. We hypothesised that severity or disease reporting dif-
fered by age group and estimated age-dependent reporting rates (ρyoung and ρold) and the age at
which reporting rates changed (Athreshold). However due to the wide age bands of the available
data, we were not able to explore this fully. Full details are given in the S1 Text.
Since the majority of notified dengue cases are diagnosed as secondary dengue infections
[4,5,7,11,12,59], we assumed that the probability of detecting a primary case would be smaller
than the probability of detecting a secondary case, and that the probability of detecting a ter-
tiary or quaternary case would be smaller than the probability of detecting a primary case
(γ3<γ1<ρ). The probability of detecting a primary case was consistently low relative to a sec-
ondary case (Fig 3) at less than 50%, the majority being under 25%. However, we were not able
to estimate the probability of detecting a tertiary/quaternary case (relative to a primary case)
from the available data. A prospective cohort study in Nicaragua found that the proportion of
Fig 5. Posterior median estimates of the total force of infection from themodel fitted to incidence data (model 1) andmodel A (as
described in [13]) to age-stratified seroprevalence data (serology) from Thailand where incidence and serology data were
available from the same year and location.
doi:10.1371/journal.pntd.0004833.g005
Estimating Dengue Transmission Intensity from Incidence Data
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004833 July 11, 2016 11 / 15
inapparent to symptomatic infection did not differ according to whether an individual had a
primary, secondary, or tertiary infection [60].
Overall, the impact of cross-immunity and the contribution of tertiary and quaternary
infections to onward transmission are not well quantified. While there is evidence that tertiary
and quaternary infections occur [61,54], there is little quantitative data on the infectiousness or
severity of such infections relative to primary and secondary infections. Additionally, clinically
apparent tertiary or quaternary infections are not routinely reported, nor can they be tested for
retrospectively [61]. Wikramaratna et al. showed that tertiary and quaternary infections allows
for the high seroprevalence at very young ages observed in Haiti [62] and Nicaragua [63] better
than when assuming complete protection after two heterologous infections [61].
Since the majority of dengue infections are mild or asymptomatic, even sensitive healthcare
systems can substantially underestimate true rates of infection even for the supposedly more
severe secondary infections, as shown by the low baseline reporting rates [11,3]. Furthermore,
dengue has a wide spectrum of clinical manifestations making it difficult to accurately diagnose
in the first instance [20]. Our estimates from Thailand (Fig 5) shows that even with data from
the same location and year, it is difficult to make reliable comparisons between estimates
obtained from seroprevalence and incidence data. We were also comparing force of infection
estimates from seroprevalence data to those from incidence data from a single year (rather
than cumulative incidence), which may have contributed to the observed discrepancy.
Although incidence data are the most abundant form of data available on dengue transmission,
surveillance systems and reporting procedures are not standardised within or across countries
making it very difficult to reliably compare estimates [20]. Laboratory capacity and general
public health infrastructure and surveillance systems vary widely and there is often no integra-
tion between private and public health sectors. With such variable data, it is very difficult to
estimate dengue burden (or transmission intensity) consistently. Since non-serotype specific
serological (IgG) surveys are relatively inexpensive to collect, it would be beneficial for such
seroprevalence data to be collected routinely. Such data would provide better baseline estimates
of overall transmission intensity against which incidence based-estimates could be calibrated to
assess changes in transmission and identify weaknesses in surveillance systems.
Supporting Information
S1 Text. Supporting information file containing methods, results, and extra figures.
(PDF)
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